Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2028 250

  1. Primary completion Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07353749

  2. Study completion Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07531394

  3. Study completion rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07606807

  4. Primary completion rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07606807

  5. Study completion Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756398

  6. Primary completion Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846579

  7. Study completion Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07934563

  8. Primary completion Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07934563

  9. Study completion Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex AAAs Using Fenestrated- Branched Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02266719

  10. Primary completion Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex AAAs Using Fenestrated- Branched Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02266719

  11. Study completion Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02322840

  12. Primary completion Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323581

  13. Study completion Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02830152

  14. Study completion Epinephrine Dose: Optimal Versus Standard Evaluation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03826524

  15. Primary completion Epinephrine Dose: Optimal Versus Standard Evaluation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03826524

  16. Study completion Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03968393

  17. Primary completion Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03968393

  18. Study completion BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04666454

  19. Primary completion BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04666454

  20. Study completion MLC1501 Study Assessing Efficacy in STROke Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05046106

  21. Study completion Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05105321

  22. Study completion MYTHS - MYocarditis THerapy With Steroids Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05150704

  23. Study completion Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05262803

  24. Primary completion Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05262803

  25. Study completion Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05367037

  26. Primary completion Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05367037

  27. Study completion The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05508035

  28. Study completion Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05543278

  29. Study completion Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05627375

  30. Primary completion ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05672836

  31. Study completion Anticoagulation in Post MI LV Thrombus Trial in Nepal Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05794399

  32. Primary completion Anticoagulation in Post MI LV Thrombus Trial in Nepal Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05794399

  33. Study completion First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05939076

  34. Study completion Strategy for Improving Stroke Treatment Response Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05948566

  35. Primary completion First Responder Airway & Compression Rate Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05969028

  36. Study completion Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06099730

  37. Primary completion Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06099730

  38. Study completion Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06207383

  39. Primary completion Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06217302

  40. Study completion Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06310031

  41. Study completion Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486012

  42. Study completion MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06543082

  43. Primary completion MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06543082

  44. Primary completion ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06716021

  45. Study completion Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06746233

  46. Primary completion Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06746233

  47. Study completion Alleviant ALLAY-HFrEF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06812533

  48. Primary completion Alleviant ALLAY-HFrEF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06812533

  49. Study completion Safety of Short-course of NSAIDs in Pediatric Patients With CKD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06860711

  50. Study completion TaVNS for Acute Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06918964

  51. Study completion CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06959121

  52. Study completion Postpartum Evaluation of Nifedipine and Enalapril for Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023003

  53. Study completion High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059728

  54. Study completion TRicuspid Uk STudy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133386

  55. Primary completion TRicuspid Uk STudy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133386

  56. Study completion Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181382

  57. Primary completion Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181382

  58. Study completion Minocycline in Stroke Study at Maimonides Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237048

  59. Study completion Dronedarone Rhythm Intervention for Early Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270848

  60. Study completion Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07302854

  61. Primary completion Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07302854

  62. Study completion A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07318155

  63. Study completion Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07338175

  64. Primary completion OPTION-EMEA Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349121

  65. Primary completion The Southern-Norway Post-Stroke Atrial Fibrillation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07407790

  66. Study completion Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07475949

  67. Primary completion Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07475949

  68. Study completion The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07513883

  69. Study completion Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583446

  70. Primary completion Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583446

  71. Study completion Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594301

  72. Primary completion Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594301

  73. Study completion Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594314

  74. Primary completion Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07594314

  75. Study completion GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617155

  76. Study completion MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07632157

  77. Primary completion MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07632157

  78. Primary completion Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644234

  79. Study completion An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07661381

  80. Primary completion An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07661381

  81. Primary completion Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07719894

  82. Study completion Systematic Ambulatory ECG Monitoring Following TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739316

  83. Primary completion Systematic Ambulatory ECG Monitoring Following TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739316

  84. Study completion Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07824323

  85. Study completion Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835178

  86. Primary completion Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835178

  87. Study completion OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07855614

  88. Primary completion Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07926854

  89. Study completion SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05852704

  90. Study completion Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07866066

  91. Primary completion Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07066137

  92. Study completion A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07218029

  93. Primary completion A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07218029

  94. Study completion Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05611242

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke Registry record

    Expected 2024-10-30; that period ended on 2024-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645522

  2. Primary completion A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02785120

  3. Study completion The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03163329

  4. Study completion IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797832

  5. Primary completion IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797832

  6. Study completion IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04849325

  7. Primary completion Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04907123

  8. Study completion Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05326490

  9. Study completion Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580068

  10. Primary completion Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580068

  11. Primary completion EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05584319

  12. Primary completion Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05600387

  13. Primary completion Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06197022

  14. Study start Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06604611

  15. Study start Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy Registry record

    Expected 2024-10; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660940

  16. Study start The Androtriol Injection for the Treatment of Acute Ischemic Stroke Registry record

    Expected 2024-10-31; that period ended on 2024-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06679322

  17. Study completion Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05625711

  18. Study start Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06091176

  19. Primary completion Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06256211

  20. Study start The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06471699

  21. Study start Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06616961

  22. Study completion the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients Registry record

    Expected 2024-11-01; that period ended on 2024-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06653946

  23. Study completion A Study of Distal Jejunal-release Dextrose in Obese Participants Registry record

    Expected 2024-11-11; that period ended on 2024-11-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05385978

  24. Primary completion A Study of Distal Jejunal-release Dextrose in Obese Participants Registry record

    Expected 2024-11-11; that period ended on 2024-11-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05385978

  25. Study completion Effect of Dapagliflozin on VT in Patients With Heart Failure. Registry record

    Expected 2024-11-15; that period ended on 2024-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05550441

  26. Primary completion Effect of Dapagliflozin on VT in Patients With Heart Failure. Registry record

    Expected 2024-11-15; that period ended on 2024-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05550441

  27. Study start Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Registry record

    Expected 2024-11-20; that period ended on 2024-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587347

  28. Study start Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome Registry record

    Expected 2024-11-20; that period ended on 2024-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06703788

  29. Primary completion Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Registry record

    Expected 2024-11-24; that period ended on 2024-11-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05950516

  30. Primary completion A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. Registry record

    Expected 2024-11-28; that period ended on 2024-11-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05246410

  31. Primary completion Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window Registry record

    Expected 2024-11-28; that period ended on 2024-11-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05634382

  32. Study completion Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism Registry record

    Expected 2024-11-30; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04088292

  33. Primary completion Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT Registry record

    Expected 2024-11-30; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04702373

  34. Study completion Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation Registry record

    Expected 2024-11-30; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05459974

  35. Primary completion Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO Registry record

    Expected 2024-11-30; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05577195

  36. Primary completion The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes Registry record

    Expected 2024-11; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05844644

  37. Primary completion EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Registry record

    Expected 2024-11; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06138834

  38. Study start Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention Registry record

    Expected 2024-11; that period ended on 2024-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06682351

  39. Study completion Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03454724

  40. Study completion Diabetes Discharge Transitional CGM Study (DDT-CGM) Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04729985

  41. Study completion Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04853758

  42. Primary completion Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04853758

  43. Study completion Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05309460

  44. Primary completion Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05624203

  45. Primary completion Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05649488

  46. Study completion Safety and Efficacy of Evolocumab in Ischemic Stroke Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05697185

  47. Primary completion A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05783557

  48. Study completion Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301451

  49. Primary completion Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301451

  50. Study start Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome Registry record

    Expected 2024-12-01; that period ended on 2024-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06723002

  51. Study start Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation Registry record

    Expected 2024-12-10; that period ended on 2024-12-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645249

  52. Study completion Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism Registry record

    Expected 2024-12-16; that period ended on 2024-12-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06164379

  53. Primary completion Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism Registry record

    Expected 2024-12-16; that period ended on 2024-12-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06164379

  54. Primary completion Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction Registry record

    Expected 2024-12-20; that period ended on 2024-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05604976

  55. Primary completion Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA Registry record

    Expected 2024-12-20; that period ended on 2024-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06196047

  56. Study completion Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification Registry record

    Expected 2024-12-29; that period ended on 2024-12-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05539898

  57. Study completion Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04093336

  58. Primary completion Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04093336

  59. Study completion ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04476173

  60. Study completion Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04702373

  61. Primary completion Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04762472

  62. Study completion A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05246410

  63. Study completion Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05392712

  64. Primary completion Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis(Timing Trial) Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05574972

  65. Study completion Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05624203

  66. Primary completion A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05673525

  67. Primary completion DCB Under the Guidance of OCT in STEMI Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05680051

  68. Study completion Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05756309

  69. Primary completion Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05756309

  70. Study completion Empagliflozin to Prevent Post-Operative Atrial Fibrillation Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06124937

  71. Primary completion Empagliflozin to Prevent Post-Operative Atrial Fibrillation Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06124937

  72. Study completion Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06196047

  73. Study completion Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06256211

  74. Primary completion Analysis of the Efficacy and Stability of a Wearable ECG Monitor Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06546046

  75. Study start QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension Registry record

    Expected 2024-12-30; that period ended on 2024-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06716970

  76. Study completion Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01450722

  77. Primary completion Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01450722

  78. Study completion Early Mobilization After Achilles Tendon Rupture Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02318472

  79. Primary completion Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02342444

  80. Study completion A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02785120

  81. Primary completion Controlling and Lowering Blood Pressure With the MobiusHD™ Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02827032

  82. Study completion Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02928094

  83. Study completion The Effect of Isokinetic Strengthening Training Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02938416

  84. Primary completion The Effect of Isokinetic Strengthening Training Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02938416

  85. Study completion Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03234114

  86. Primary completion Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03234114

  87. Primary completion Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252626

  88. Study completion VitaFlowTM II Transcatheter Aortic Valve System Study Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03575039

  89. Study completion Metformin as RenoProtector of Progressive Kidney Disease Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03831464

  90. Primary completion Metformin as RenoProtector of Progressive Kidney Disease Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03831464

  91. Primary completion A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03998319

  92. Study completion Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04088513

  93. Primary completion Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04088513

  94. Primary completion Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04160000

  95. Primary completion Optimising Pacing for Contractility 2 Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04201015

  96. Study completion Use of Telemonitoring to Facilitate Heart Failure Medication Titration Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04205513

  97. Study completion A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04255602

  98. Primary completion A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04255602

  99. Study completion Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease Registry record

    Expected 2024-12; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04258397

  100. Study completion Effects of Preferential Left Ventricular Pacing on Ventriculoarterial Coupling and Clinical Course of Heart Failure Registry record

    Expected 2024-12-31; that period ended on 2024-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04420065